Nexalin Technology (NXL) EBIAT (2022 - 2025)
Historic EBIAT for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to -$2.3 million.
- Nexalin Technology's EBIAT rose 702.32% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7 million, marking a year-over-year decrease of 5624.79%. This contributed to the annual value of -$7.6 million for FY2024, which is 6364.07% down from last year.
- Per Nexalin Technology's latest filing, its EBIAT stood at -$2.3 million for Q3 2025, which was up 702.32% from -$1.6 million recorded in Q2 2025.
- In the past 5 years, Nexalin Technology's EBIAT ranged from a high of -$135401.0 in Q3 2022 and a low of -$2.8 million during Q4 2024
- For the 4-year period, Nexalin Technology's EBIAT averaged around -$1.3 million, with its median value being -$1.0 million (2024).
- Its EBIAT has fluctuated over the past 5 years, first plummeted by 159658.2% in 2023, then surged by 702.32% in 2025.
- Quarter analysis of 4 years shows Nexalin Technology's EBIAT stood at -$729677.0 in 2022, then fell by 6.99% to -$780669.0 in 2023, then crashed by 262.93% to -$2.8 million in 2024, then grew by 19.66% to -$2.3 million in 2025.
- Its EBIAT stands at -$2.3 million for Q3 2025, versus -$1.6 million for Q2 2025 and -$2.0 million for Q1 2025.